ladostigil novel neuroprotective agent investigated treatment neurodegenerative disorders like alzheimers disease lewy body disease parkinsons acts reversible acetylcholinesterase butyrylcholinesterase inhibitor irreversible monoamine oxidase b inhibitor combines mechanisms action older drugs like rivastigmine rasagiline single addition neuroprotective properties ladostigil enhances expression neurotrophic factors like gdnf bdnf may capable reversing damage seen neurodegenerative diseases via induction ladostigil also antidepressant effects may useful treating comorbid depression anxiety often seen diseases httpsenwikipediaorgwikiladostigil